Insight Molecular Diagnostic

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.29

+0.19 (+3.73%)

As of May 16, 2:05 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +229.1% upside

Low Target $14.05

Average Target $17.41

High Target $26.42

Current Price $5.29

Current
$5.29

Target
$17.41

$14.05 $17.41 avg $26.42

Scenario Analysis

Bear Case

$14.05

165.6%

Low target

Base Case

$17.41

+229.1%

Avg target

Bull Case

$26.42

+399.4%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$8.51

-37.8% from high

52-Week Low

$2.33

+127.0% from low

Target vs 52W High

$17.41

+104.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%